These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9107599)

  • 21. Universal influenza vaccination in the United States: are we ready? Report of a meeting.
    Schwartz B; Hinman A; Abramson J; Strikas RA; Allred N; Uyeki T; Orenstein W
    J Infect Dis; 2006 Nov; 194 Suppl 2():S147-54. PubMed ID: 17163388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
    Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
    Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community.
    Praditsuwan R; Assantachai P; Wasi C; Puthavatana P; Kositanont U
    J Med Assoc Thai; 2005 Feb; 88(2):256-64. PubMed ID: 15962680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine cost-effective, but underused.
    Nurs Manage; 2002 Oct; 33(10):10. PubMed ID: 12408137
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults.
    Muennig PA; Khan K
    Clin Infect Dis; 2001 Dec; 33(11):1879-85. PubMed ID: 11692300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
    Schmier J; Li S; King JC; Nichol K; Mahadevia PJ
    Health Aff (Millwood); 2008; 27(2):w96-104. PubMed ID: 18216044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
    Hibbert CL; Piedra PA; McLaurin KK; Vesikari T; Mauskopf J; Mahadevia PJ
    Vaccine; 2007 Nov; 25(47):8010-20. PubMed ID: 17936446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness of prophylaxis and treatment of influenza].
    Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prophylactic influenza vaccination: what is the situation in Germany?].
    Wutzler P
    Dtsch Med Wochenschr; 2006 Mar; 131(9):453-7. PubMed ID: 16493571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modelling the health-economic impact of the next influenza pandemic in The Netherlands.
    Hak E; Meijboom MJ; Buskens E
    Vaccine; 2006 Nov; 24(44-46):6756-60. PubMed ID: 16797797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of influenza vaccination in elderly Australians: an exploratory analysis of the vaccine efficacy required.
    Newall AT; Dehollain JP
    Vaccine; 2014 Mar; 32(12):1323-5. PubMed ID: 24486359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare influenza vaccine demonstration--selected states, 1988-1992.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Mar; 41(9):152-5. PubMed ID: 1741007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmaco-economics of anti-influenza vaccinations].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health benefits, risks, and cost-effectiveness of influenza vaccination in children.
    Fleming DM; Elliot AJ
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S154-8. PubMed ID: 18955891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influenza vaccination].
    Bleisch F
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1091-5. PubMed ID: 9691343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-wide benefits of routine vaccination of children against influenza.
    Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
    Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Policy evaluation for the subsidy for influenza vaccination in elderly.
    Ohkusa Y
    Vaccine; 2005 Mar; 23(17-18):2256-60. PubMed ID: 15755606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic value of influenza vaccination.
    de Waure C; Veneziano MA; Cadeddu C; Capizzi S; Specchia ML; Capri S; Ricciardi W
    Hum Vaccin Immunother; 2012 Jan; 8(1):119-29. PubMed ID: 22251999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research.
    Longini IM
    Pediatrics; 2012 Mar; 129 Suppl 2():S63-7. PubMed ID: 22383483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.